Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederdrugs.com
Drugs.com - New Drug Approvals
Get the latest updates from Drugs.com - New Drug Approvals directly as they happen.
Follow now 77 followers
Latest posts
Last updated about 14 hours ago
FDA Approves Vybrique (sildenafil) Oral Film to Treat Men with Erectile Dysfunction
4 days ago
Parsippany, NJ, February 5, 2026 – IBSA USA, the U.S. subsidiary of...
Novo Nordisk Introduces Ozempic Pill; Available in the US Q2 2026
5 days ago
PLAINSBORO, N.J., February 4, 2026 – Novo Nordisk today announced that the...
FDA Approves Yuvezzi (carbachol and brimonidine tartrate) Ophthalmic Solution to Treat Presbyopia
12 days ago
LONDON, U.K. and SEATTLE, Wash., January 28, 2026 – Tenpoint Therapeutics, Ltd...
Darzalex Faspro-Based Quadruplet Regimen Approved for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible
13 days ago
HORSHAM, Pa., January 27, 2026 – Johnson & Johnson (NYSE:JNJ) announced today...
MannKind Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy
14 days ago
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) --...
Organon Announces US FDA Approval of Supplemental New Drug Application Extending Duration of Use of Nexplanon (etonogestrel implant) for Up to Five Years
24 days ago
JERSEY CITY, N.J.--(BUSINESS WIRE) January 16, 2026 -- Organon (NYSE: OGN), a...
FDA Approves Filkri (filgrastim-laha), a Biosimilar to Neupogen
25 days ago
January 15, 2026 - The U.S. Food and Drug Administration has approved...
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
27 days ago
Solana Beach, CA – JANUARY 13, 2026 – Sentynl Therapeutics Inc. (“Sentynl”)...
FDA Approves Zycubo (copper histidinate) for Children With Menkes Disease
28 days ago
January 12, 2026 -- The U.S. Food and Drug Administration today approved...
FDA Approves Nereus (tradipitant) for the Prevention of Motion Sickness
about 1 month ago
WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)...
FDA Approves Yartemlea (narsoplimab-wuug) for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
about 2 months ago
SEATTLE--(BUSINESS WIRE)--Dec. 24, 2025-- Omeros Corporation (NASDAQ: OMER) today announced that the...
FDA Approves Aqvesme (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
about 2 months ago
CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq...